SHANGHAI, March 22, 2022 /PRNewswire/ -- Qiming Venture Partners' portfolio company Arrail Group (S...
SHANGHAI, March 2, 2022 /PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm inC...
HONG KONG, Feb. 14, 2022 /PRNewswire/ -- Recently, Pluslife Biotech, an enterprise based in the Gre...
SHANGHAI, Jan. 7, 2022 /PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm inCh...
SHANGHAI, Jan. 4, 2022 /PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm inCh...
SHANGHAI, Dec. 10, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company CANbridge Pharma...
SHANGHAI, Nov. 15, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Aohua Endoscopy ...
SHANGHAI, Oct. 19, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Microtech Medic...
SHANGHAI, Oct. 15, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Abbisko (SEHK:22...
SHANGHAI, Sept. 24, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Broncus (SEHK:2...
SHANGHAI, Aug. 16, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Sino Biological ...
SHANGHAI, April 28, 2021 /PRNewswire/ -- Qiming's portfolio company Fanli.com went public today on ...
SHANGHAI, April 13, 2021 /PRNewswire/ -- Forbes today released the 2021 Midas List, a ranking of th...
SHANGHAI, March 27, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Zhihu (NYSE: ZH...
SHANGHAI, March 20, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Connect Biophar...
SHANGHAI, Feb. 18, 2021 /PRNewswire/ -- Qiming's portfolio company New Horizon Health (SEHK:6606)...
SHANGHAI and BEIJING and HONG KONG, Jan. 26, 2021 /PRNewswire/ -- Qiming Venture Partners ("Qiming"...
SHANGHAI, Jan. 7, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company APT Medical (SHSE...
SHANGHAI, Nov. 20, 2020 /PRNewswire/ -- Qiming's portfolio company Antengene (SEHK: 6996) officiall...
SHANGHAI, Nov. 18, 2020 /PRNewswire/ -- Qiming Venture Partners today announced the final closing o...